Resibufagin | CAS No. 20987-24-0

Resibufagin

Basic Information

View in Editor

CAS Number

20987-24-0

Molecular Formula

C24H30O5

Molecular Weight

398.5 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Aldehydes

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Physical State

Powder

SMILES

View in Editor

CC12CCC3C(C14C(O4)CC2C5=COC(=O)C=C5)CCC6C3(CCC(C6)O)C=O

InChI

InChI=1S/C24H30O5/c1-22-8-7-17-18(4-3-15-10-16(26)6-9-23(15,17)13-25)24(22)20(29-24)11-19(22)14-2-5-21(27)28-12-14/h2,5,12-13,15-20,26H,3-4,6-11H2,1H3/t15-,16+,17+,18-,19?,20-,22-,23-,24-/m1/s1

InChIKey

LFLJTMIVTFTLOA-UIZOPSFESA-N

LogP

3.4373000000000022

Topological Polar Surface Area

80.03999999999999 Å²

Hydrogen Bond Donor/Acceptor

1 / 5

Complexity

831

Safety Information

View Safety Information

Storage Conditions

2-8℃

Synonyms & References

English

RESIBUFAGIN
(3beta,5beta,15beta)-14,15-Epoxy-3-hydroxy-19-oxobufa-20,22-dienolide
NSC 234206
Resibufagin
A-bufa-20,22-dienolide
1ST162361
Bufa-20, 14,15-epoxy-3-hydroxy-19-oxo-, (3.beta.,5.beta.,15.beta.)-
E88863
(1R,2S,4R,7R,10S,11R,14S,16R)-14-hydroxy-7-methyl-6-(6-oxopyran-3-yl)-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecane-11-carbaldehyde
5.beta.-Bufa-20, 14,15.beta.-epoxy-3.beta.-hydroxy-19-oxo-
(1R,2S,4R,7R,10S,11R,14S,16R)-14-hydroxy-7-methyl-6-(6-oxopyran-3-yl)-3-oxapentacyclo[8.8.0.0(2),?.0(2),?.0(1)(1),(1)?]octadecane-11-carbaldehyde
A-Epoxy-3
14,15
NSC-234206
DTXSID60474925
A-hydroxy-19-oxo-5
NSC234206
A,14
20987-24-0

MDL Number

MFCD30533746

FAQ

What regulatory guidelines apply to Resibufagin (CAS: 20987-24-0)?

Resibufagin (CAS: 20987-24-0) requires adherence to GHS classification for hazardous chemicals, REACH regulations for registration, evaluation, authorization, and restriction of chemicals in the EU, and FDA/EPA guidelines for safety and environmental protection. It is essential to follow local and international regulations for storage, handling, and disposal.

Are there alternatives to Resibufagin (CAS: 20987-24-0) in synthesis?

Alternatives to Resibufagin (CAS: 20987-24-0) in synthesis include bufadienolides and other cardiac glycosides like digoxin and ouabain. These compounds can serve as similar reagents in drug synthesis and research, offering varying levels of effectiveness and toxicity.

What is the market or research trend for Resibufagin (CAS: 20987-24-0)?

The research trend for Resibufagin (CAS: 20987-24-0) focuses on its potential as a cardioprotective agent and in the development of anticancer drugs. Market dynamics indicate increasing interest in its pharmacological properties, particularly in cardiovascular and oncology drug research.

How should waste containing Resibufagin (CAS: 20987-24-0) be handled?

Waste containing Resibufagin (CAS: 20987-24-0) should be collected in sealed containers and disposed of through professional waste disposal services. Incineration or other environmentally safe methods should be employed, following local and international environmental protection regulations to minimize environmental impact.